Inhibition of anxiety in rats by antisense to cholecystokinin precursor protein

Biological Psychiatry

Volumn 44, Issue 9, 1998, Pages 915-917

  Cohen, Hagit ^a   Kaplan, Zeev ^a   Kotler, Moshe ^a  

^a MENTAL HEALTH CENTER   (Israel)

Author keywords

Animal model; Antisense oligodeoxynucleotide; Anxiety; Cholecystokinin

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CHOLECYSTOKININ; OLIGODEOXYNUCLEOTIDE; PROTEIN PRECURSOR;

ANIMAL CELL; ANIMAL TISSUE; ANXIETY NEUROSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; INHIBITION KINETICS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; RNA TRANSLATION;

ANIMALS; ANXIETY; CHOLECYSTOKININ; DRUG ADMINISTRATION SCHEDULE; EXPLORATORY BEHAVIOR; INJECTIONS, INTRAVENOUS; MALE; MAZE LEARNING; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; PROTEIN PRECURSORS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0032213210     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00010-9     Document Type: Article

References (19)

1. Abe J.I., Zhou W., Taguchi J.I., Takuwa N., Miki K., Okazaki H., et al. Suppression of neointimal smooth muscle cell accumulation in vivo by antisense CDC2 and CDK2 oligonucleotides in rat carotid artery. Biochem Biophys Res Commun. 198:1994;16-24.
2. Akabayashi A., Wahlestedt C., Alexander J.T., Leibowitz S.F. Specific inhibition of endogenous neuropeptide Y synthesis in arcuate nucleus by antisense oligonucleotides suppresses feeding behavior and insulin secretion. Brain Res Mol Brain Res. 1:(2):1994;55-61.
3. Amaratunga A., Morin P.J., Kosik K.S., Fine R. Inhibition of kinesin synthesis and rapid anterograde axonal transport in vivo by an antisense oligonucleotide. J Biol Chem. 268:1993;17427-17430.
4. Bourin M., Malinge M., Bradwejn J. Two faces of cholecystokinin Anxiety and schizophrenia . Fundam Clin Pharmacol. 10:1996;116-126.
5. Cohen H., Kaplan Z., Kotler M. Intracerebroventricular (icv) administration of CCK-antisense oligodeoxynucleotides prevents anxiety-behavior in rats. Eur Neuropsychopharmacol. 6:1996;153-154.
6. Crawley JN (1994): Interactions between cholecystokinin and other neurotransmitter systems. In: Bradwejn J, editor. Cholecystokinin and Anxiety, from Neuron to Behavior. Biomedical Publishers, CRC Press.
7. Eck S.L., Nabel G.J. Antisense oligonucleotides for therapeutic intervention. Curr Opin Biotechnol. 2:1991;897-904.
8. File S.E. The interplay of learning and anxiety in the elevated plus maze. Behav Brain Res. 58:1993;199-202.
9. Helene C., Toulme J.J. Specific regulation of gene expression by antisense, sense and antigene nucleic acids. Biochem Biophys Acta. 1049:1990;99-125.
10. Kitajima I., Shinohara T., Minor T., Bibbs L., Bilakovics J., Nerenberg M. Human T-cell leukemia virus type I tax transformation is associated with increased uptake of oligodeoxynucleotides in vitro and in vivo. J Biol Chem. 267:1992;25881-25888.
11. Kofman O., Bersudsky Y., Vinnitsky I., Alpert C., Belmaker R.H. The effect of peripheral inositol injection on rat motor activity models of depression. Israel J Med Sci. 29:1993;580-586.
12. Kramer M.S., Cutler N.R., Ballenger J.C., Patterson W.M., Mendels J., Chenault A., et al. A placebo-controlled trial of L-365,260, a CCK-B antagonist, in panic disorder. Biol Psychiatry. 37:1995;462-466.
13. McCarthy M.M., Schlenker E., Pfaff D.W. Enduring consequences of neonatal treatment with antisense oligodeoxynucleotides to estrogen receptor mRNA on sexual differentiation on rat brain. Endocrinology. 133:1993;433-439.
14. Sand A.O., Catsicas M., Staple J.K., Jones K.A., Ayala G., Knowles J., et al. Inhibition of axonal growth by SNAP-25 antisense oligonucleotides in vitro and in vivo. Nature. 364:1993;445-448.
15. Simons M., Edelman E.R., DeKeyser J.L., Langer R., Rosenberg R.D. Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature. 359:1992;67-70.
16. Skutella T., Probst J.C., Caldwell J.D., Pedersen C.A., Jirikowski G.F. Antisense oligodeoxynucleotide complementary to oxytocin mRNA blocks lactation in rats. Exp Clin Endocrinol Diabetes. 103:1995;191-195.
17. Uhlmann E., Peyman A. Antisense oligonucleotides A new therapeutic principle . Chem Rev. 90:1990;544-583.
18. Wagner R.W. Gene inhibition using antisense oligodeoxynucleotides. Nature. 372:1994;24.
19. Wahlestedt C., Pich E.M., Koob G.F., Yee F., Heilig M. Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligonucleotides. Science. 259:1993;528-531.